You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Mendus Q1’24: Progress with main partnerships
Mendus made progress with main partnerships in Q1. CEO Erik Manting comments on the topic and other main events of Q1 as well as upcoming events in this interview.
Content:
00:00 Intro
00:18 Q1 in a nutshell
03:37 CADENCE
06:08 Milestones for building a capability for pivotal stage
08:05 Vididencel
11:29 Ilixadencel
14:19 NK cells